Whole Slide Scanner At No Upfront Cost

OptraSCAN is a leading end-to-end digital pathology solution provider has launched On-Demand digital pathology business model in England to strengthen the adoption of digital pathology. Pathology labs, healthcare networks, and hospitals can effortlessly adopt digital pathology solutions without any upfront cost and at affordable pricing solutions.

OptraSCAN support laboratories arrive at the optimal configuration of slide scanning instruments required to process efficiently their case throughput. We also offer an On-Demand business model to ensure the most compelling approach possible to financing digitization.

The seamless integration of OptraSCAN provides:

Walk away automation
Slides are scanned in less than a minute at 40x equivalent
Cloud-based whole slide imaging systems
Well-equipped for confocal, brightfield, fluorescence, and frozen section applications
Integrated image management and viewing
Real-time and remote viewing & collaboration
Quantitative and reproducible image analysis

The whole slide scanners that are available with this model are brightfield scanners – OS-Ultra, OS-15, and fluorescence scanners – OS-FL and OS-FLi.

OS-Ultra is a high-speed whole slide digital pathology scanner that scans tissues/cells of size 15×15 mm area at 40x equivalent in less than 60 seconds. OS-Ultra features a unique no-touch slide loading mechanism to diminish workflow errors and produce high-resolution images. The high-speed scanner comes with solutions – IMAGEPath®, the Image Management System apt for viewing, storing and archiving, and TELEPath®, Telepathology software used for real-time, and remote consultations.

Features:

Slide capacity – 80, 160, 320, and 480 slides
Continual slide loading capacity
Slides scanned at 0.25 microns per pixel (the equivalent of 40x)
Scanning time is less than a minute for 15×15 mm region
Patented composite imaging for cytology samples
Images generated up to 0.1 microns per pixel (the equivalent of 80x)
OS-Ultra high-speed whole slide scanner with Noiseless operation
Storage
Local
Cloud

Cytology Image analysis
Morphology tools for Breast and Prostate
IHC biomarker panel for ER/ PR / Her2neu / Ki67 / P53 / EGFR
PD-L1
OS-15 Histopathology and H&E Brightfield Scanners are cloud-enabled to provide the ultimate flexibility for storing, archiving, and managing digital images and metadata. This small footprint, low throughput scanners are lightweight and easily fit into small workspaces. Whole slide scanning is now convenient with high-resolution imaging. OptraSCAN’s Cloud-enabled solutions such as IMAGEPath®, the Image Management System apt for viewing, storing, and archiving as well as TELEPath®, Telepathology software used for real-time, remote consultations are included with OS-15 scanners.

Features:

Cloud-enabled 15-slide Brightfield
Desktop Scanning
20x & 40x magnification
Small footprint

OptraSCAN’s digital pathology scanners are easy to implement and can be integrated in any existing HIS and LIS.

This solution will further assist pathologists and cytologists to adopt digital pathology solutions in the UK.

Benefits of OptraSCAN’s Digital Pathology Solutions?

Provides the pathologist community much-needed flexible working model with a minimum upfront investment
Enables users to focus on their core areas of working without any technological and operational burdens
Supports easy scalability & integration within the user’s existing eco-system
Augments efficient workflows for multi-site collaboration, anytime & anywhere access
Allows integrated real-time remote connectivity for expert opinions & consultations
Offers great opportunities for education, research and supervision opine

Procedure To Register Section 8 Company In India

The section-8 company works only for social welfare without earning any profit. The main objective is to promote & development of society, protection of the earth, living creatures, environment and also promote education, arts, science, commerce, literature, etc. It is registered under companies act either as a private limited company or public limited company as required but there is no need to mention “private limited” or “limited” at the end of the name. It has all the features like private limited or public limited company Minimum of 2 people are required if it is started as a private limited company and 7 if it is started as a public limited company. There is no need to have any minimum capital amount to start section 8 company registration, it can be started with Rs. 100/- capital as well. The government will grant the license for social activity at the time of issuance of the certificate of incorporation which is valid until it is surrendered or revoked by the government itself. The registration is valid for the lifetime but to maintain the active status the company has to do annual compliances every year it includes ROC filing, ITR, KYC, preparation of balance sheet, profit & loss a/c, conducting board meeting and general meetings etc. if the company fails to do these compliances, then there is penalty provision which the company and directors have to face.

Documents Required For Section 8 company Registration:

Shareholder/ Director

PAN
Aadhar card
Id proof (driving license/ passport/ voter id); anyone
Address proof (electricity bill/ mobile bill/ telephone bill/ bank statement); anyone
Registered office address proof

Sale deed or house tax receipt if owned and rent agreement if rented
Utility bill (electricity bill/ mobile bill/ telephone bill/ gas bill); anyone
NOC from the person whose name is mentioned in the bill
NOTE: The address proof as mentioned above should be latest and not be older than 2 months.

Procedure to register the section-8 company:

Name Reservation: The name is a very important part of every company and it should be unique and reserved by the government as well. The section-8 company is exempted from using the word “private limited”, “Pvt Ltd”, “limited”, “ltd”, etc. at the end of their name instead of these words they can use “Foundation”, “Association”, “Organization”, etc.
Digital Signature Certificate: The Digital Signature is also known as DSC; it is equivalent to the physical signature and no forms can be filed until it is signed with the DSC. For DSC there are few verifications that the applicant has to make.
Drafting & Signing of Documents: After name approval, it is valid for 20 days only and the procedure must be completed on these days only. After the name is approved there are certain documents that shall be drafted and signed by the directors and shareholders of the company.
Submission of Final Form: After preparation of all documents as well as DSC then the only final form needs to file to the government along with all relevant and required documents and information. And if the registrar is satisfied with all the information and documents then they will issue Certificate of Incorporation, License, PAN, TAN, and DIN of the directors.

What is Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis?

DelveInsight’s “Antibody Drug Conjugate- Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Antibody Drug Conjugate, historical and forecasted epidemiology as well as the Antibody Drug Conjugate market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

What is Antibody Drug Conjugate Market Report?

The Antibody Drug Conjugate market report provides current treatment practices, emerging drugs, Antibody Drug Conjugate market share of the individual therapies, current and forecasted Antibody Drug Conjugate market Size from 2018 to 2030 segmented by seven major markets. The Report also covers current Antibody Drug Conjugate treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Antibody Drug Conjugate Disease Understanding and Treatment Algorithm

The DelveInsight Antibody Drug Conjugate market report gives a thorough understanding of the Antibody Drug Conjugate by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Antibody Drug Conjugate.

Treatment

It covers the details of conventional and current medical therapies available in the Antibody Drug Conjugate market for the treatment of the condition. It also provides Antibody Drug Conjugate treatment algorithms and guidelines in the United States, Europe, and Japan.

Antibody Drug Conjugate Epidemiology

The Antibody Drug Conjugate epidemiology division provide insights about historical and current Antibody Drug Conjugate patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Antibody Drug Conjugate epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Antibody Drug Conjugate Epidemiology

The epidemiology segment also provides the Antibody Drug Conjugate epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Antibody-Drug Conjugate Drug Chapters

Drug chapter segment of the Antibody Drug Conjugate report encloses the detailed analysis of Antibody Drug Conjugate marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Antibody Drug Conjugate clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Antibody Drug Conjugate treatment.

Antibody-Drug Conjugate Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Antibody Drug Conjugate treatment.

Antibody Drug Conjugate Market Outlook

The Antibody Drug Conjugate market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Antibody Drug Conjugate market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Antibody Drug Conjugate market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

Antibody Drug Conjugate Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Antibody Drug Conjugate market or expected to get launched in the market during the study period 2018-2030. The analysis covers Antibody Drug Conjugate market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Antibody Drug Conjugate Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Antibody Drug Conjugate key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Antibody Drug Conjugate emerging therapies.

Reimbursement Scenario in Antibody Drug Conjugate

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME’s opinion working in Antibody Drug Conjugate domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Antibody Drug Conjugate market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Antibody Drug Conjugate Market by using various Competitive Intelligence tools that include – SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Wrinkle Cream Ratings Usually Consider Four Product Aspects

The benefit of wrinkle cream ratings is that it gives you an idea of the creams on the market. Thanks to the flourishing cosmetic industry and the growing trend of hiding age, the market is flooded with large numbers of anti-aging formulas.

• What formula is best for you?
• What really works?
• What is truly needed?

You get the answers to all these questions and more through product ratings.

The good thing is you can easily access wrinkle cream ratings online today. However, have you ever wondered how these ratings are compiled? Ah, once you get your hands on the perfect anti wrinkle cream, you may not care how they are compiled at all. For the curious souls who wish to know what aspects of each product are scrutinized for the ratings, here it is.

Product Aspects Considered for Wrinkle Cream Ratings

Ingredients – Although the ingredients for anti-aging formulas are almost the same, some products may contain an additional ingredient or miss one or two, or have them in varying amounts. This drastically affects the effectiveness of the product. Also, the safety of the product changes with the use or omission of ingredients. That is why a cream suited to one person may not suit another.
Effectiveness – A product that has no visible effect even after using it for a month or so is considered useless. Most of the anti-wrinkle formulas are aimed at diminishing, if not completely curing wrinkles. The rating is calculated by how fast and efficiently the cream works.
Cost – Who doesn’t want an anti wrinkle facial cream that costs less? Well, there are people who are willing to pay exorbitant amounts of money to their plastic surgeons for getting the look. However, it is only because they “have to,” not “want to.” Provide them with a perfect anti-aging formula and they would probably stop Botox treatments and plastic surgery at once. Cost matters much. Wrinkle cream ratings are calculated by considering how efficiently a cream works for price paid for it.
Brand name – People tend to choose reputable brands. Somebody who has never used a beauty product in their life may also choose to try a product from a known name in the cosmetic industry. But, even the top brands need to maintain their quality to remain in the top ratings.

Wrinkle cream ratings can prove to be a useful tool in choosing a product. Asking people who have already used the product is another good way to judge its rating. The advantage of ratings is that they cover consumers from a wider area. They tell you what cream is popular. New successful launches also play a role in the ratings game.

Remember, you cannot completely evaluate a product without actually using it. So, use wrinkle cream ratings only as a guideline.